Dapsone therapy for refractory immune thrombocytopenia patients: a case series

BACKGROUND: Dapsone has been recommended as a second-line immunosuppressive agent for patients with immune thrombocytopenia (ITP). METHODS: We retrospectively analyzed the efficacy and safety of dapsone therapy in patients with ITP. RESULTS: Nine ITP patients were treated with dapsone at a dose of 5...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Ji Yun, Lee, Jeong-Ok, Jung, Joo Young, Bang, Soo-Mee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5503904/
https://www.ncbi.nlm.nih.gov/pubmed/28698844
http://dx.doi.org/10.5045/br.2017.52.2.95

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5503904/
https://www.ncbi.nlm.nih.gov/pubmed/28698844
http://dx.doi.org/10.5045/br.2017.52.2.95

Ejemplares similares